Atlas Trials

Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion

Clinical trial NCT04947423 · COMPLETED

Trial details

NCT number
NCT04947423
Sponsor
Repurposed Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Motion Sickness
Start date
2021-06-14
Primary completion
2021-08-12
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.